Differences in the optimization of pharmacological treatment in patients with heart failure and reduced ejection fraction and advanced chronic kidney disease.

Back

HFA Premium Access

Differences in the optimization of pharmacological treatment in patients with heart failure and reduced ejection fraction and advanced chronic kidney disease.

Session: Chronic heart failure - comorbidities 1

Topic: Comorbidities

Speaker: Doctor R. Gonzalez-Manzanares (Cordoba, ES)

Event: Heart Failure 2024

Congress Presentation

Add to my library

About the speaker

Doctor Rafael Gonzalez-Manzanares

Reina Sofia University Hospital, Cordoba (Spain)

1 presentation

0 follower

6 more presentations in this session

Risk of heart failure in type 1 diabetes compared with type 2 diabetes: insights from the UK Biobank

Speaker: Doctor M. Vaduganathan (Boston, US)

Access

Abstract

Slides

Respiratory muscle strength in ischemic cardiomyopathy and COVID-19 patients.

Speaker: Doctor E. Gutierrez Luna (Mexico, MX)

Urinary albumin-to-creatinine ratio and progression of heart failure

Speaker: Doctor A. Abdi (Tehran, IR)

Ultrasound-measured quadriceps thickness and mortality in older patients with heart failure

Speaker: Doctor Y. Fujimoto (Tokyo, JP)

Cardio-Kidney-metabolic overlap in HFpEF: cardiac structure and function, clinical outcomes, and response to sacubitril/valsartan in PARAGON-HF

Speaker: Doctor M. Lassen (Boston, US)

Access the full session

Chronic heart failure - comorbidities 1

Speakers: Doctor R. Gonzalez-Manzanares, Doctor M. Vaduganathan, Doctor E. Gutierrez Luna, Doctor A. Abdi, Doctor Y. Fujimoto...

Access

About the event

Heart Failure 2024

11 May - 14 May 2024

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources